Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases- Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

被引：140

作者：

Bhattacharya, Debika ^{[1
]}

Aronsohn, Andrew ^{[2
]}

Price, Jennifer ^{[3
]}

Lo Re, Vincent, III ^{[4
,5
]}

机构：

[1] Univ Calif Los Angeles, Dept Med, Div Infect Dis, David Geffen Sch Med, Los Angeles, CA USA

[2] Univ Chicago, Dept Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL USA

[3] Univ Calif San Francisco, Dept Med, Div Gastroenterol & Hepatol, San Francisco, CA USA

[4] Univ Penn, Dept Med, Div Infect Dis, Perelman Sch Med, Philadelphia, PA USA

[5] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA USA

来源：

CLINICAL INFECTIOUS DISEASES | 2023年

关键词：

HCV screening; direct-acting antivirals; HCV guidance; HCV treatment; HCV prevention; ACTING ANTIVIRAL THERAPY; INJECTION-DRUG USE; LEDIPASVIR PLUS SOFOSBUVIR; GENOTYPE; INFECTION; HIV-POSITIVE MEN; UNITED-STATES; OPEN-LABEL; SINGLE-ARM; TRANSPLANT RECIPIENTS; PREGNANT-WOMEN;

D O I：

10.1093/cid/ciad319

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have collaboratively developed evidence-based guidance regarding the diagnosis, management, and treatment of hepatitis C virus (HCV) infection since 2013. A panel of clinicians and investigators with extensive infectious diseases or hepatology expertise specific to HCV infection periodically reviews evidence from the field and update existing recommendations or introduce new recommendations as evidence warrants. This update focuses on changes to the guidance since the previous 2020 published update, including ongoing emphasis on recommended universal screening; management recommendations for incomplete treatment adherence; expanded eligibility for simplified chronic HCV infection treatment in adults with minimal monitoring; updated treatment and retreatment recommendations for children as young as 3 years; management and treatment recommendations in the transplantation setting; and screening, treatment, and management recommendations for unique and key populations.

引用

页数：18

共 169 条

[1] Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection [J].

Ghany M.G. ;

Morgan T.R. .

HEPATOLOGY, 2020, 71 (02) :686-721

[2] Pregnancy outcome of anti-HCV direct-acting antivirals: Real-life data from an Egyptian cohort [J].

AbdAllah, Mohamed ;

Alboraie, Mohamed ;

Abdel-Razek, Wael ;

Hassany, Mohamed ;

Ammar, Islam ;

Kamal, Ehab ;

Alalfy, Mahmoud ;

Okasha, Ahmed ;

El Akel, Wafaa ;

Shaaban, Elsaied ;

Elbaz, Tamer ;

Hefny, Zeinab ;

Gomaa, Ahmed ;

El-Bendary, Mahmoud ;

El-Serafy, Magdy ;

Esmat, Gamal ;

Doss, Wahid ;

El-Sayed, Manal H. .

LIVER INTERNATIONAL, 2021, 41 (07) :1494-1497

[3]

ACCF/AHA Task Force on Practice Guidelines, 2010, Methodology manual and policies from the ACCF/AHA Task Force on Practice Guidelines

[4] HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men [J].

Adu, Prince A. ;

Rossi, Carmine ;

Binka, Mawuena ;

Wong, Stanley ;

Wilton, James ;

Wong, Jason ;

Butt, Zahid A. ;

Bartlett, Sofia ;

Jeong, Dahn ;

Pearce, Margo ;

Darvishian, Maryam ;

Yu, Amanda ;

Alvarez, Maria ;

Garcia, Hector A. Velasquez ;

Krajden, Mel ;

Janjua, Naveed Z. .

LIVER INTERNATIONAL, 2021, 41 (03) :482-493

[5] Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients [J].

Agarwal, Kosh ;

Castells, Lluis ;

Mullhaupt, Beat ;

Rosenberg, William M. C. ;

McNabb, Brian ;

Arterburn, Sarah ;

Camus, Gregory ;

McNally, John ;

Stamm, Luisa M. ;

Brainard, Diana M. ;

Subramanian, G. Mani ;

Marino, Zoe ;

Dufour, Jean-Francois ;

Forns, Xavier .

JOURNAL OF HEPATOLOGY, 2018, 69 (03) :603-607

[6] Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy A Randomized Controlled Trial [J].

Akiyama, Matthew J. ;

Norton, Brianna L. ;

Arnsten, Julia H. ;

Agyemang, Linda ;

Heo, Moonseong ;

Litwin, Alain H. .

ANNALS OF INTERNAL MEDICINE, 2019, 170 (09) :594-+

[7] Hepatitis C Screening of the "Birth Cohort" (Born 1945-1965) and Younger Inmates of New York City Jails [J].

Akiyama, Matthew J. ;

Kaba, Fatos ;

Rosner, Zachary ;

Alper, Howard ;

Holzman, Robert S. ;

MacDonald, Ross .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (07) :1276-1277

[8] HCV-Positive Allograft Use in Heart Transplantation Is Associated With Increased Access to Overdose Donors and Reduced Waitlist Mortality Without Compromising Outcomes [J].

Altshuler, Peter J. ;

Helmers, Mark R. ;

Schiazza, Alexis R. ;

Hu, Robin ;

Han, Jason J. ;

Herbst, D. Alan ;

Iyengar, Amit ;

Atluri, Pavan .

JOURNAL OF CARDIAC FAILURE, 2022, 28 (01) :32-41

[9]

American College of Obstetricians and Gynecologists, PRACT ADV ROUT HEP C

[10] Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004 [J].

Amon, Joseph J. ;

Garfein, Richard S. ;

Ahdieh-Grant, Linda ;

Armstrong, Gregory L. ;

Ouellet, Lawrence J. ;

Latka, Mary H. ;

Vlahov, David ;

Strathdee, Steffanie A. ;

Hudson, Sharon M. ;

Kerndt, Peter ;

Jarlais, Don Des ;

Williams, Ian T. .

CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1852-1858

← 1 2 3 4 5 6 7 8 9 10 →